Lighthizer: Raise Tariffs on Everything Made in China
The China tariffs, enacted by Lighthizer under Trump, are under review later this year. Will they stay or will they go? Lighthizer thinks they should stay…with more tariffs added.
Are Americans Investing in Chinese Forced Labor Companies?
The House Select Committee on the CCP published a preliminary report on the use of forced labor in Shein and Temu supply chains. Many Americans are investors.
Supply Chain Crisis, Not Tariffs, Stoked Inflation
Don’t blame the China tariffs on inflation. Supply chain snafus were a much bigger deal, a Federal Reserve report says.
Taiwan Agreement Risks Treasury Rewriting Customs Law Globally
On June 1, 2023, the United States and Taiwan signed “the first agreement under the U.S.-Taiwan Initiative on 21st Century Trade.” “Initiative”? “21st Century Trade”?
Katherine Tai Says Globalization No Longer Sustainable
At National Press Club, Katherine Tai talks about supply chain issues, what ‘de-risking’ from China might look like, and how USTR thinks about it.
FDA Allows Uninspected China Lab to Sell Cancer Drugs in the US
A Chinese cancer drug maker that has not been inspected by the FDA since 2018 is selling chemotherapy drugs to the U.S. due to shortages. When will the U.S. meet its critical medication needs?
House Hearing on Dollar Focused on Sanctions Powers, ‘De-Dollarization’ Risks
The House Financial Services Committee says American consumers are helped by a strong dollar, which lowers the price of imports to the tune of up to $45 billion per year in savings. In a $23 trillion economy, is an overvalued dollar really worth it?
U.S. Trade Deficit Rises 23% in April; Goods Gap Breaks Record For Year
China as a source for American imports is on the wane thanks to tariffs, other business risks. But strong dollar keeps imports booming.
Job Quality Index Rises, Goods-Producing Job Growth Continues to Slow
WASHINGTON — The Coalition for a Prosperous America (CPA) today announced that the U.S. Private Sector Job Quality Index (JQI) for April was 84.46, up 0.25% from March.
To Fight Drug Shortages FDA Has an Idea: Import More Inspection-Free Drugs
The balance between scarcity and supply favors supply, even if that means importing drugs from labs the FDA has not inspected.
